Mesabi Trust (MSB NYSE) stock market data APIs
$31.2232
0.16(0.5%)
as of September 15, 2025
Try our APIs with
free plan!
Mesabi Trust Financial Data Overview
Price chart is built with
Anychart
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. The company was incorporated in 1961 and is based in New York, New York.
Prev. Close
31.2232
Open
31.3822
High
31.7978
Low
31.0701
52 wk Range
16.4068-33.25
Market Cap
412 M
P/E Ratio
4.4157
Shares Outstanding
13 120 K
Revenue
25 895 K
EPS
0.2768
Dividends (Yield)
0.2254
Beta
0.548
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Mesabi Trust (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mesabi Trust data using free add-ons & libraries
Get Mesabi Trust Fundamental Data
Mesabi Trust Fundamental data includes:
- Net Revenue: 25 895 K
- EBITDA:
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mesabi Trust News
New
Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commerc...
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has entered into c...
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
Mesoblast Limited NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it h...
Mesoblast Full Year 2025 Earnings: Misses Expectations
Mesoblast (ASX:MSB) Full Year 2025 Results Key Financial Results Revenue: US$17.2m (up 191% from FY 2024). Net loss: US$102.1m (loss widened by 16% from FY 2024). US$0.085 loss per share. Trump has...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
